Age-Related Macular Degeneration

Age-Related Macular Degeneration (Macular Degeneration)

1. General Information
   Age-related macular degeneration (AMD) is a disease that occurs with the involvement of the macula region located in the center of the retina and particularly impairs central vision. It is usually seen after the age of 50 and has two main types: dry (atrophic) and wet (neovascular).
2. Treatment Methods

• In dry type AMD, the main approach is regular follow-up, lifestyle adjustments, and appropriate vitamin–antioxidant supports.
• In wet type AMD, the most effective treatment method is intraocular injections (anti-VEGF), which aims to slow the progression of the disease.
• In suitable patients, the treatment plan is determined individually according to the stage of the disease.

1. Regenerative Treatments and Stem Cell Approaches
   In recent years, studies on stem cells and cellular treatments have become a research topic, especially for dry type macular degeneration.
   These treatments;

• Supporting the function of retinal cells,
• Reducing inflammation around the tissue,
• Promoting healing processes at the cellular level
  are evaluated as supportive and complementary approaches.

Based on current scientific data, stem cell applications do not replace standard treatments, but can be considered as a supportive option in appropriately selected patients.

1. Recovery Process

• AMD is a chronic disease and treatment is usually long-term.
• Intraocular injections are applied at regular intervals and require close follow-up.
• In regenerative treatments, the process is personalized, and results may vary depending on the type and stage of the disease.

1. Advantages

• Progression of central vision loss can be slowed with early diagnosis and appropriate treatment.
• Visual function can be preserved in wet type AMD with modern injection treatments.
• Regenerative approaches can offer complementary support to existing treatments in selected patients.

1. Limitations

• The disease cannot be completely eliminated, it is controlled.
• Treatment effectiveness depends on the stage of the disease.
• Stem cell applications are still a developing field and are not suitable for every patient.
• Regular follow-up and systemic health control are of great importance.